-
Description
Neostigmine Juno Methylsulfate Injection 2.5mg/1ml Ampoule
Neostigmine Juno Methylsulfate Injection is a cholinesterase inhibitor used in the management of myasthenia gravis and as a reversal agent for non-depolarizing neuromuscular blocking agents after surgery. This product is meticulously formulated to ensure precise dosing and efficacy for critical applications in various medical settings.
Product Specifications:
- Concentration: 2.5mg of Neostigmine Methylsulfate per 1ml
- Volume: 1ml per ampoule
- Presentation: Clear, colorless, sterile solution
- Packaging: Securely sealed ampoules to ensure product integrity
- Storage: Store between 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F)
Common Applications:
- Reversal of neuromuscular blockade induced by non-depolarizing muscle relaxants
- Symptomatic treatment of myasthenia gravis
- Use in diagnostic procedures for myasthenia gravis
User Groups:
- Anesthesiologists and CRNAs (Certified Registered Nurse Anesthetists)
- Neurologists
- Emergency Medicine Physicians
- Medical professionals in surgical and critical care settings
Supplier Overview:
APOTEX is a globally recognized leader in the pharmaceutical industry, renowned for their commitment to quality, safety, and efficacy in medication development and manufacturing. With a robust portfolio of more than 300 generic pharmaceuticals, APOTEX has established itself as an authority in providing affordable and reliable healthcare solutions. Their expertise in the production of injectable medications, such as Neostigmine Juno Methylsulfate Injection, is backed by stringent quality control processes and state-of-the-art manufacturing facilities, ensuring that healthcare professionals and patients receive products that meet the highest standards of pharmaceutical excellence.
